Trial Profile
A trial to assess FOLFIRINOX alone, or in combination with bevacizumab or cetuximab, in patients with metastatic colorectal cancer treated in French centres
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Cetuximab (Primary) ; Fluorouracil; Irinotecan; Levofolinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Aug 2015 New trial record